Intrathecal cannabinoid administration suppresses noxious stimulus- evoked Fos protein-like immunoreactivity in rat spinal cord: Comparison with morphine

Acta Pharmacologica Sinica

Volumn 20, Issue 12, 1999, Pages 1132-1136

  Hohmann, Andrea G ^a,b   Kang, Tsou ^a   Walker, J Michael ^a  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

Cannabinoids; Fos genes; Mu opioid receptors; Nociceptors; Pain measurement; Spinal cord

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CANNABINOID; MORPHINE SULFATE; PROTEIN C FOS;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; INTRATHECAL DRUG ADMINISTRATION; MALE; NOCICEPTIVE STIMULATION; NONHUMAN; ONCOGENE C FOS; PAIN ASSESSMENT; RAT; SPINAL CORD; SPINAL CORD DORSAL HORN;

ANALGESICS; ANIMALS; CANNABINOIDS; CYCLOHEXANOLS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, SPINAL; MALE; MORPHINE; NOCICEPTORS; PAIN; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD;

EID: 13044258892     PISSN: 02539756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Hohmann AG, Martin WJ, Tsou K, Walker JM. Inhibition of noxious stimulus-evoked activity of spinal cord dorsal horn neurons by the cannabinoid WEM 55,212-2. Life Sci 1995; 56: 2111-8.
2. Hohmann AG, Tsou K, Walker JM. Cannabinoid modulation of wide dynamic range neurons in the lumbar dorsal horn of the rat by spinally administered WIN55, 212-2. Neurosci Lett 1998; 257: 119-22.
3. Hohmann AG, Tsou K, Walker JM. Cannabinoid suppression of noxious heat-evoked activity in wide dynamic range neurons in the lumbar dorsal horn of the rat. J Neurophysiol 1999; 81: 575-83.
4. Tsou K, Lowitz KA, Hohmann AG, Martin WJ, Hathaway CB, Bereiter DA, et al. Suppression of noxious stimulus-evoked expression of FOS protein-like immunoreactivity in rat spinal cord by a selective cannabinoid agonist. Neuroscience 1996; 70: 791-8.
5. Martin WJ, Hohmann AG, Walker JM. Suppression of noxious stimulus-evoked activity in the ventral posterolateral nucleus of the thalamus by a cannabinoid agonist: correlation between electrophysiological and antinociceptive effects. J Neurosci 1996; 16: 6601-11.
6. Lichtman AH, Martin BR. Spinal and supraspinal components of cannabinoid-induced antinociception. J Pharmacol Exp Ther 1991; 258: 517-23.
7. Martin WJ, Lai NK, Patrick SL, Tsou K, Walker JM. Antinociceptive actions of cannabinoids following intraventricular administration in rats. Brain Res 1993; 629: 300-4.
8. 9-tetrahydrocannabinol-induced analgesia. Brain Res 1992; 578: 8-12.
9. Yaksh TL. The antinociceptive effects of intrathecally administered levonantradol and desacetyllevonantradol in the rat. J Clin Pharmacol 1981; 21: 334S-40S.
10. Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 1991; 11: 563-83.
11. 1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: a double-label in situ hybridization study. Neuroscience 1999; 90: 923-31.
12. Hohmann AG, Briley EM, Herkenham M. Pre- and postsynaptic distribution of cannabinoid and mu opioid receptors in rat spinal cord. Brain Res 1999; 822: 17-25.
13. Hohmann AG, Herkenham M. Regulation of cannabinoid and mu opioid receptor binding sites following neonatal capsaicin treatment. Neurosci Lett 1998; 252: 13-6.
14. Martin WJ, Patrick SL, Coffin PO, Tsou K, Walker JM. An examination of the central sites of action of cannabinoid-induced antinociception in the rat. Life Sci 1995; 56: 2103-9.
15. Yaksh TL, Rudy TA. Chronic catheterization of the spinal subarachnoid space. Physiol Behav 1979; 17: 1031-6.
16. Strangman NM, Patrick SL, Hohmann AG, Tsou K, Walker JM. Evidence for a role of endogenous cannabinoids in the modulation of acute and tonic pain sensitivity. Brain Res 1998; 813: 323-8.
17. Abbott FV, Franklin KB, Westbrook RF. The formalin test: scoring properties of the first and second phases of the pain response in rats. Pain 1995; 60: 91-102.
18. Welch SP, Stevens DL. Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice. J Pharmacol Exp Ther 1992; 262: 10-8.
19. 1 receptors in the rat central nervous system. Neuroscience 1998; 83: 393-411.
20. Hammond DL, Wang H, Nakashima N, Basbaum AI. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat. J Pharmacol Exp Ther 1998; 284: 378-87.